Does CHA2DS2-VASc Improve Stroke Risk Stratification in Postmenopausal Women with Atrial Fibrillation?
Does CHA2DS2-VASc Improve Stroke Risk Stratification in Postmenopausal Women with Atrial Fibrillation?
复制标题
DOI：
10.1016/j.amjmed.2013.05.023
复制
发表时间：
2013-12-01
影响因子：
5.9
通讯作者：
Wassertheil-Smoller, Sylvia
中科院分区：
文献类型：
--
作者：
Abraham, JoEllyn M.;Larson, Joseph;Wassertheil-Smoller, Sylvia
背景技术：对患有充血性心力衰竭（C）、高血压（H）、年龄≥ 75（A）、糖尿病（D）、卒中或短暂性脑缺血发作（TIA）（S-2）（CHADS（2））评分≥ 75（A（2））、糖尿病（D）、卒中、TIA或既往血栓栓塞性疾病（S-2）-血管疾病（V）、年龄65-74（A）的房颤患者进行风险分层，女性（S）（CHA（2）DS（2）-VASc）卒中风险评分，并确定CHA（2）DS（2）-VASc是否进一步对CHADS（2）评分为
BACKGROUND: Risk stratification of atrial fibrillation patients with a congestive heart failure (C), hypertension (H), age >= 75 (A), diabetes (D), stroke or transient ischemic attack (TIA) (S-2) (CHADS(2)) score of = 75 (A(2)), diabetes (D), stroke, TIA or prior thromboembolic disease (S-2)- vascular disease (V), age 65-74 (A), female gender (S) (CHA(2)DS(2)-VASc) stroke risk scores in a healthy cohort of American women with atrial fibrillation and to determine whether CHA(2)DS(2)-VASc further risk-stratifies individuals with a CHADS(2) score of